Aloe barbadensis Mill. formulation restores lipid profile to normal in a letrozole-induced polycystic ovarian syndrome rat model

Pharmacognosy Research

Volumn 4, Issue 2, 2012, Pages 109-115

  Desai, Bhavna N ^a   Maharjan, Radha H ^a   Nampoothiri, Laxmipriya P ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Aloe vera gel; anovulation; anti hyperlipidemic effect; dyslipidemia; hyperandrogenism; infertility; insulin resistance; letrozole; polycystic ovarian syndrome

Indexed keywords

ALOE BARBADENSIS EXTRACT; ALOE VERA EXTRACT; ATORVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LETROZOLE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ALOE; ALOE VERA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; DRUG FORMULATION; DYSLIPIDEMIA; ENZYME ACTIVITY; ESTRUS CYCLE; FEMALE; GLUCOSE METABOLISM; HYPERGLYCEMIA; LIPID BLOOD LEVEL; NONHUMAN; OVARY POLYCYSTIC DISEASE; RAT; STEROIDOGENESIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84859795933     PISSN: None     EISSN: 09748490     Source Type: Journal    
DOI: 10.4103/0974-8490.94736     Document Type: Article

References (41)

1. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile. J Clin Endocrinol Metab 1999;84:4006-11. (Pubitemid 30644187)
2. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study. J Clin Endocrinol Metab 1998;83:3078-82. (Pubitemid 28500937)
3. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434-8. (Pubitemid 32269197)
4. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-9. (Pubitemid 38766360)
5. Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in indian adolescents. J Pediatr Adolesc Gynecol 2011;24:223-7.
6. Azziz R. Controversy in clinical endocrinology: Diagnosis of polycystic ovarian syndrome: The Rotterdam criteria are premature. J Clin Endocrinol Metab 2006;91:781-5. (Pubitemid 43357736)
7. Guzick DS. Polycystic ovary syndrome. Obstet Gynecol 2004;103:181-93. (Pubitemid 39248484)
8. Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
9. Wild RA. Long-term health consequences of PCOS. Hum Reprod Update 2002;8:231-41. (Pubitemid 34618942)
10. Wild RA, Rizzo M, Clifton S, Carmina E. Lipid levels in polycystic ovary syndrome: Systematic review and meta-analysis. Fertil Steril 2011;95:1073-9.
11. Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. Ann N Y Acad Sci 1995;748:399-406.
12. Sathyapalan T, Kilpatrick ES, Coady AM, Atkin SL. Atorvastatin pretreatment augments the effect of metformin in patients with polycystic ovary syndrome (PCOS). Clin Endocrinol 2010;4:566-8.
13. Kazerooni T, Shojaei-Baghini A, Dehbashi S, Asadi N, Ghaffarpasand F, Kazerooni Y. Effects of metformin plus simvastatin on polycystic ovary syndrome: A prospective, randomized, double-blind, placebo-controlled study. Fertil Steril 2010;6:2208-13.
14. Sangraula H, Paudel KR, Sharma M. Metformin and troglitazone in the treatment of female infertility associated with polycystic ovarian syndrome. JNMA J Nepal Med Assoc 2009;176:335-9.
15. Rizzo M, Berneis K, Carmina E, Rini GB. How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome? Am J Obstet Gynecol 2008;198:28.
16. Hoffmann IS, Roa M, Torrico F, Cubeddu LX. Ondansetron and metformin-induced gastrointestinal side effects. Am J Ther 2003;10:447-51.
17. Corrao G, Zambon A, Bertù L, Botteri E, Leoni O, Contiero P. Lipid lowering drugs prescription and the risk of peripheral neuropathy: An exploratory case-control study using automated databases. J Epidemiol Community Health 2004;58:1047-51. (Pubitemid 39564208)
18. Golomb BA, Kwon EK, Koperski S, Evans MA. Amyotrophic lateral sclerosis-like conditions in possible association with cholesterol-lowering drugs: An analysis of patient reports to the University of California, San Diego (UCSD) statin effects study. Drug Saf 2009;32:649-61.
19. Vasu VT, Modi H, Thaikoottathil JV, Gupta S. Hypolipidaemic and antioxidant effect of Enicostemma littorale Blume aqueous extract in cholesterol fed rats. J Ethnopharmacol 2005;101:277-82. (Pubitemid 41265633)
20. Ram A, Lauria P, Gupta R, Kumar P, Sharma VN. Hypocholesterolaemic effects of Terminalia arjuna tree bark. J Ethnopharmacol 1997;55:165-9. (Pubitemid 27122303)
21. Sortibrán AC, Téllez MG, Ocotero VM, Carballo-Ontiveros MA, García AM, Valdés RJ, et al. Chronic toxicity, genotoxic assay, and phytochemical analysis of four traditional medicinal plants. J Med Food 2011;14:1018-22.
22. Pérez YY, Jiménez-Ferrer E, Zamilpa A, Hernández- Valencia M, Alarcón-Aguilar FJ, Tortoriello J, et al. Effect of a polyphenol-rich extract from Aloe vera gel on experimentally induced insulin resistance in mice. Am J Chin Med 2007;35:1037-46.
23. Rajasekaran S, Ravi K, Sivagnanam K, Subramanian S. Beneficial effects of aloe vera leaf gel extract on lipid profile status in rats with streptozotocin diabetes. Clin Exp Pharmacol Physiol 2006;33:232-7.
24. Habeeb F, Stables G, Bradbury F, Nong S, Cameron P, Plevin R, et al. The inner gel component of Aloe vera suppresses bacterial-induced pro-inflammatory cytokines from human immune cells. Methods 2007;42:388-93. (Pubitemid 46856869)
25. Anilakumar KR, Sudarshanakrishna KR, Chandramohan G, Ilaiyaraja N, Khanum F, Bawa AS. Effect of Aloe vera gel extract on antioxidant enzymes and azoxymethane-induced oxidative stress in rats. Indian J Exp Biol 2010;48:837-42.
26. Maharjan R, Nagar PS, Nampoothiri L. Effect of Aloe vera gel extract on Letrozole induced Polycystic Ovarian Syndrome (PCOS) Rat Model. J Ayurveda Integr Med 2010;4:273-9.
27. Kafali H, Iriadam M, Ozardali I, Demir N. Letrozole induced polycystic ovaries in the Rat: A new model for Cystic Ovarian Disease. Arch Med Res 2004;35:103-8. (Pubitemid 38316828)
28. Ali M, Eftekhar M, Taheripanah R. Effect of administration of metformin on lipid profile changes and insulin resistance in patients with PCOS. Middle East Fertil Soc J 2007;12:174-8. (Pubitemid 351182983)
29. Dostal LA, Whitfield LR, Anderson JA. Fertility and general reproduction studies in rats with the HMG-CoA reductase inhibitor, atorvastatin. Fundam Appl Toxicol 1996;32:285-92.
30. Buchanan TA, Sipos GF, Gadalah S, Yip KP, Marsh DJ, Hsueh W, et al. Glucose tolerance and insulin action in rats with renovascular hypertension. Hypertension 1991;18:341-7.
31. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957;226:497-509.
32. Zlatkis A, Zak B, Boyle AJ. A new method for the direct determination of serum cholesterol. J Lab Clin Med 1953;41:486-92.
33. Rao AV, Ramakrishnan S. Indirect assessment of HMG-CoA Reductase (NADPH) activity in liver. Clin Chem 1975;21:1523-5.
34. Hitz J, Steinmetz J, Siest G. Plasma lecithin cholesterol acyl transferase-Reference values and effects of xenobiotics. Clin Chim Acta 1983;133:85-93.
35. Yen SS. The polycystic ovary syndrome. Clin Endocrinol (Oxf) 1980;12:177-208.
36. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, et al. Androgen excess in women: Experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004;89:453-62. (Pubitemid 38269843)
37. Liepa GU, Sengupta A, Karsies D. Polycystic ovary syndrome (PCOS) and other androgen excess related conditions: Can change in dietary intake make a difference? Nutr Clin Pract 2008;23:63.
38. Bjorntorp P. The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord 1996;20:291-302. (Pubitemid 26110403)
39. Conway GS, Agrawal R, Betteridge DJ, Jacobs HS. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf) 1992;37:119-25.
40. Von Eckardstein A. Androgens, cardiovascular risk factors, and atherosclerosis. In: Nieschlag E, Behre HM (eds). Testosterone: Action, Deficiency, Substitution. 2 nd ed. Springer, Berlin Heidelberg New 1998. p. 229-58.
41. Croston GE, Milan LB, Marschke KB, Reichman M, Briggs MR. Androgen receptor-mediated antagonism of estrogen-dependent low density lipoprotein receptor transcription in cultured hepatocytes. Endocrinology 1997;138:3779-86. (Pubitemid 27351929)